Conditions in dogs
Start from the problem rather than the compound. Each page covers what the condition actually is, which compounds are investigated for it, and how far the evidence goes.
The short answer
The canine conditions with the most relevant peptide research are soft tissue and orthopaedic injury — tendon and ligament damage, CCL tears, post-surgical recovery — where BPC-157 and TB-500 have the most mechanistic support, and wound healing, where GHK-Cu has a published canine study. Evidence is weakest, and risk highest, in canine cancer, where several otherwise-useful compounds are actively contraindicated.
Hip dysplasia
A malformed hip joint that leads to instability, cartilage wear, and secondary arthritis, most common in large and giant breeds.
Osteoarthritis
Progressive cartilage loss and joint inflammation, affecting a large share of dogs over eight years old.
Cranial cruciate ligament (CCL) tear
Rupture of the stabilising ligament in the stifle, the single most common orthopaedic injury in dogs.
Intervertebral disc disease (IVDD)
Degeneration and herniation of spinal discs causing pain, weakness, or paralysis — a defining risk in chondrodystrophic breeds.
Wound healing
Repair of surgical incisions, lacerations, ulcers, and chronic non-healing wounds.
Post-surgical recovery
Supporting tissue repair, comfort, and return to function after an orthopaedic or soft tissue procedure.
IBD and gut health
Chronic inflammation of the intestinal lining causing vomiting, diarrhoea, and weight loss.
Senior dog mobility
The combined effect of arthritis, muscle loss, and reduced activity that limits older dogs.
Tendon and ligament injury
Strains, partial tears, and chronic tendinopathies in working, sporting, and active dogs.
Immune support
Supporting immune function in dogs with recurrent infection, chronic illness, or immunosuppression.
Canine cancer support
Investigational adjuncts alongside veterinary oncology care. The most experimental area covered here.
Skin and coat
Coat quality, hair regrowth, and chronic dermatologic conditions.
Muscle wasting
Loss of muscle mass from age, disuse, chronic illness, or prolonged rest after injury.